Loading...
NPI 1386961548 · Warwick, RI · Ophthalmology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Tatyana Serednyakova is a ophthalmology physician provider located in Warwick, Rhode Island. This profile covers 14 Medicare and 2 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Tatyana Serednyakova |
| Address | 566 Toll Gate Rd |
| City | Warwick |
| State | RI |
| ZIP | 02886 |
| Taxonomy | Ophthalmology Physician |
| NPI Enumerated | April 28, 2010 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.3M |
| Medicaid | $6.4K |
TATYANA SEREDNYAKOVA is predominantly a Medicare-facing ophthalmology practice by revenue: lifetime Medicare revenue is $1.3M versus Medicaid revenue of $6.4K, indicating Medicare dominates this provider's payer mix and that Medicaid is a very small contributor to overall billed revenue. The long-enumerated NPI (registered ~2010-04-28, ~16 years ago) supports an established clinical presence in WARWICK, RI focused on eye care services.
Medicare revenue is highly concentrated in a small set of intravitreal injection codes: precomputed results show the top three Medicare codes account for 88.5% of the provider's Medicare revenue. The single highest-cost Medicare code is J0178 (aflibercept injection), which alone represents the largest share of Medicare revenue ($865.1K, 64.9% of Medicare revenue), indicating the practice’s business model is heavily weighted toward anti-VEGF retinal injections.
Operationally, the mix of high-revenue codes (J0178 and J2777) combined with procedure codes such as 67028 (intravitreal injection) and diagnostic imaging codes like 92134 suggests the provider operates as a retina/injection-focused ophthalmology practice that performs frequent intravitreal medication administration and retinal imaging rather than predominantly general ophthalmic office visits. The presence of substantial volume in 92134 (retinal imaging) supports routine follow-up and monitoring of retinal disease.
The provider’s competitive standing on Medicare is mixed by code: for J0178 they are at a typical national volume (rank #1046 of 3204, 67th percentile), and for J2777 they are also within a typical range (rank #1280 of 2039, 37th percentile), indicating respectable but not dominant injection volumes compared with national peers. Conversely, the E/M code 99214 shows an extreme outlier position (rank #7199 of 479517, 98th percentile) for office visit volume, suggesting unusually high utilization of mid-level established patient E/M visits relative to national peers.
On Medicaid, revenue is minimal and concentrated: the top three Medicaid codes account for 100.0% of Medicaid revenue, with 99214 accounting for $5K (77.4% of Medicaid revenue) and 92134 for $1.5K (22.6%). In-state ranking for these Medicaid codes is modest to low — 99214 ranks #1120 of 1731 (35th percentile) and 92134 ranks #22 of 24 (9th percentile) — indicating the provider is not a major Medicaid retinal services provider within Rhode Island and has very limited Medicaid scale overall.
The combination of high Medicare dependency and concentrated procedure mix creates business implications for payer and network analysts: the practice’s revenue is sensitive to reimbursement changes for intravitreal drugs (notably J0178 and J2777) and for related injection procedure reimbursement. Given that J0178 alone comprises $865.1K of Medicare revenue, any shifts in coverage, pricing, or utilization management for aflibercept could materially affect this provider’s Medicare revenue stream.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
14 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 1,250 | $690 | $865.1K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 7,020 | $30 | $203.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,200 | $90 | $112.4K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 790 | $90 | $71.8K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,320 | $30 | $41K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 130 | $80 | $10.6K |
| 92202 | The provider performs an extended ophthalmoscopy, typically with an indirect ophthalmoscope which utilizes a bright light and a hand–held indirect lens rather than the common hand–held one–piece… | 650 | $10 | $7.2K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 230 | $30 | $6.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 80 | $70 | $5.6K |
| 92235 | The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken… | 50 | $110 | $4.9K |
Showing 1–10 of 14
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 14 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
14 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 5 | 10 | 670 | $690 | $601.6K |
| J2777 | 1 | 10 | 5,790 | $30 | $158K |
| 67028 | 6 | 20 | 610 | $90 | $58.9K |
| 92014 | 83 | 190 | 120 | $80 | $16.3K |
| 99214 | 3 | 1,950 | 100 | $80 | $11.7K |
| J9035 | 15 | 20 | 160 | $50 | $9.5K |
| 99213 | 874 | 1,950 | 70 | $60 | $7.4K |
| 92134 | 7 | 120 | 50 | $30 | $6.6K |
| 99204 | 621 | 740 | 30 | $110 | $4.6K |
| 92235 | 3 | 10 | 20 | $100 | $3.6K |
Showing 1–10 of 14
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 100 | $50 | $5K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 70 | $20 | $1.5K |
How this provider's Medicaid billing volume and revenue compare to other Rhode Island providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Rhode Island median
2 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,120 | 1,730 | 220 | $70 | $75.2K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 22 | 20 | 560 | $50 | $61.6K |
Other providers in the same ZIP code as Tatyana Serednyakova, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.